Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Hematology (Amsterdam, Netherlands)
|
December 8, 2017
Antineoplastic chemotherapy in Jehovah's Witness patients with acute myelogenous leukemia refusing blood products - a matched pair analysis
Stefan Wilop, Rainhardt Osieka
Leukemia & Lymphoma
|
April 7, 2009
CpG island methylation patterns in chronic lymphocytic leukemia
Barbara Seeliger, Stefan Wilop, Rainhardt Osieka, et al.
Leukemia & Lymphoma
|
November 21, 2008
Rituximab-associated changes in platelet count in patients with non-Hodgkin lymphoma
Stefan Wilop, Oliver Galm, Reyad Dada, et al.
Deutsches Arzteblatt International
|
October 25, 2012
Surgical resection of urological tumor metastases following medical treatment
Axel Heidenreich, Stefan Wilop, Michael Pinkawa, et al.
Onkologie
|
December 9, 2008
Correlation of C-reactive protein with survival and radiographic response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer
Stefan Wilop, Martina Crysandt, Michael Bendel, et al.
Clinical Epigenetics
|
June 19, 2012
Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemia
Christoph Oing, Edgar Jost, Edgar Dahl, et al.
Acta Haematologica
|
November 6, 2009
Successful treatment of hepatic encephalopathy in a patient with acute lymphoblastic leukemia
Reyad Dada, Stefan Wilop, Edgar Jost, et al.
Onkologie
|
June 27, 2009
Cisplatin as single-agent chemotherapy in patients with liver dysfunction due to metastases
Stefan Wilop, Reyad Dada, Oliver Galm, et al.
Journal of Cancer Research and Clinical Oncology
|
April 29, 2009
Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
Stefan Wilop, Sabine von Hobe, Martina Crysandt, et al.
American Journal of Hematology
|
June 25, 2010
Sequence of administration and methylation of SOCS3 may govern response to gemtuzumab ozogamicin in combination with conventional chemotherapy in patients with refractory or relapsed acute myelogenous leukemia (AML)
Iris Middeldorf, Oliver Galm, Rainhardt Osieka, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Hematology (Amsterdam, Netherlands)
|
December 8, 2017
Antineoplastic chemotherapy in Jehovah's Witness patients with acute myelogenous leukemia refusing blood products - a matched pair analysis
Stefan Wilop, Rainhardt Osieka
Leukemia & Lymphoma
|
April 7, 2009
CpG island methylation patterns in chronic lymphocytic leukemia
Barbara Seeliger, Stefan Wilop, Rainhardt Osieka, et al.
Leukemia & Lymphoma
|
November 21, 2008
Rituximab-associated changes in platelet count in patients with non-Hodgkin lymphoma
Stefan Wilop, Oliver Galm, Reyad Dada, et al.
Deutsches Arzteblatt International
|
October 25, 2012
Surgical resection of urological tumor metastases following medical treatment
Axel Heidenreich, Stefan Wilop, Michael Pinkawa, et al.
Onkologie
|
December 9, 2008
Correlation of C-reactive protein with survival and radiographic response to first-line platinum-based chemotherapy in advanced non-small cell lung cancer
Stefan Wilop, Martina Crysandt, Michael Bendel, et al.
Clinical Epigenetics
|
June 19, 2012
Aberrant DNA hypermethylation of the ITIH5 tumor suppressor gene in acute myeloid leukemia
Christoph Oing, Edgar Jost, Edgar Dahl, et al.
Acta Haematologica
|
November 6, 2009
Successful treatment of hepatic encephalopathy in a patient with acute lymphoblastic leukemia
Reyad Dada, Stefan Wilop, Edgar Jost, et al.
Onkologie
|
June 27, 2009
Cisplatin as single-agent chemotherapy in patients with liver dysfunction due to metastases
Stefan Wilop, Reyad Dada, Oliver Galm, et al.
Journal of Cancer Research and Clinical Oncology
|
April 29, 2009
Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
Stefan Wilop, Sabine von Hobe, Martina Crysandt, et al.
American Journal of Hematology
|
June 25, 2010
Sequence of administration and methylation of SOCS3 may govern response to gemtuzumab ozogamicin in combination with conventional chemotherapy in patients with refractory or relapsed acute myelogenous leukemia (AML)
Iris Middeldorf, Oliver Galm, Rainhardt Osieka, et al.
Page
of 4